Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2026-01-04 @ 10:47 AM
Study NCT ID:
NCT01104259
Status:
COMPLETED
Last Update Posted:
2017-08-10
First Post:
2010-04-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer
Sponsor:
University of Washington
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Estrogen Receptor-negative Breast Cancer | View |
| None | HER2-negative Breast Cancer | View |
| None | Hereditary Breast/Ovarian Cancer - BRCA1 | View |
| None | Hereditary Breast/Ovarian Cancer - BRCA2 | View |
| None | Male Breast Cancer | View |
| None | Progesterone Receptor-negative Breast Cancer | View |
| None | Recurrent Breast Cancer | View |
| None | Stage IV Breast Cancer | View |
| None | Triple-negative Breast Cancer | View |
Keywords: